How this works
We count public research: papers in PubMed and trials on ClinicalTrials.gov, by the hospital that led them. Every number links to the records behind it.
Research data as of 2026-11-08. Official links last checked 2026-11-08.
What the numbers mean
- Hospital inclusion for added diseases
- One attributable paper, including Chinese-language and 2016–2020 records, or one registered study qualifies. Records with unresolved names or locations await review.
- Papers led
- English-language PubMed papers whose first or last author lists the hospital as their first affiliation. If an author lists two hospitals, only the first counts.
- Share of China's papers
- Papers led ÷ all English-language PubMed papers on the disease with a mainland-China author. The headline number on every page.
- Share of the world's papers
- Papers led ÷ all PubMed papers on the disease, any country, 2021–2025.
- Trials led
- ClinicalTrials.gov studies whose lead sponsor is the hospital. When the sponsor is only a university or a doctor, the trial goes to a hospital only if it has exactly one site in China, and is marked inferred.
- Recruiting
- Trials whose ClinicalTrials.gov status is Recruiting on the data date. Check the registry for the current status.
- University or health system
- Hospitals whose own name carries the university's name, plus papers that name only the university. Provincial and city hospitals with teaching links are not grouped.
- Map
- Hospital locations are shown at approximate city centres. The base map is Natural Earth (public domain) and is served by this site.
- Retracted papers
- Papers PubMed marks as Retracted Publication are left out of every count and list: 1190 in this data. Worldwide totals come from PubMed searches and may include a few retracted papers.
- Official lists
- The “National rare-disease network” and “National medical centre” lines on hospital pages come from official National Health Commission documents (number and date under each page). Hospitals are matched by their full Chinese name only; branch hospitals (e.g. “… Guizhou Hospital”) do not count for the parent; a few renamed hospitals were matched by hand. These are government designations; the site does not rate hospitals by them. On disease pages, “rare-disease catalogue” means China’s first and second national catalogues.
- Free full text
- Papers that have a free full text in Europe PMC get a “Free full text” link (to Europe PMC). No link does not mean the paper is closed: it may be free on the journal’s site.
- Order of lists
- Lists are sorted by share of China's papers so the most active appear first. The order is not a rating of care.
Sources
- UsedPubMed
Papers tagged with the disease, 2021–2025, with a China author address. Chinese-language papers counted separately.
- UsedClinicalTrials.gov
Studies with a site in China, including lead sponsor, study sites and registered status. Follow each record for current status and complete eligibility criteria.
- UsedOpenAlex
Institution IDs for the same papers, plus works on the topic that are not in PubMed.
- UsedROR
Institution identifiers, name variants and Chinese names.
- SampleChiCTR
Chinese trial registry. Ten IgG4-RD records were read for coverage research, outside the site’s statistics.
- UsedNational Health Commission
Notices of national diagnosis and treatment guidelines (linked under “Before contacting a hospital” on disease pages); original official lists: national rare-disease network member hospitals (2024), National Center for Neurological Disorders (2021), national and regional children's medical centres (2026), and the first and second national rare-disease catalogues (2018, 2023). Each document opened and read in a browser on 10 November 2026.
- UsedEurope PMC
Whether a paper has a free full text, and the link (identifiers and links only; no full texts downloaded).
- Not usedCDE drug trial registry
Its disclaimer forbids any commercial use of the published information, so it is not used.
- Not usedWHO ICTRP
Its terms of use (4(d)) do not allow the data to be used for marketing, promotional or commercial purposes, so it is not used.
- Not usedWanfang Med
Human-verification page on the second request.
- Not usedNSFC grants
Its robots.txt disallows automated access.
Known gaps and checks
- Only PubMed-indexed Chinese-language papers are counted. Most Chinese journals are missing, so provincial hospitals are undercounted.
- ChiCTR lists trials that are not on ClinicalTrials.gov: none of the 10 IgG4-RD records we read appeared there.
- 1404 senior-author name spellings appear at two or more hospitals. We show institutions only, not people.
- Of the 1604 hospitals listed, 399 could be linked to an OpenAlex institution. 277 of those matched a hospital-level ROR record; the other 122 are filed under their university in OpenAlex. OpenAlex and ROR matching for newly added hospitals is pending.
- Doctors move. New papers show it only months later.
| Measure | NPC | ESCC | HCC | Stomach cancer | Hepatoblastoma | Retinoblastoma | Chordoma | Osteosarcoma | Gastrointestinal stromal tumour | Neuroblastoma | Ewing sarcoma | Myeloma | B-ALL | Aplastic anaemia | HLH | Beta thalassaemia | Haemophilia A | Atypical haemolytic uraemic syndrome | Thrombotic thrombocytopenic purpura | Fanconi anaemia | NMOSD | IgG4-RD | Myasthenia gravis | Moyamoya | Wilson disease | Biliary atresia | Anti-NMDA receptor encephalitis | Takayasu arteritis | Hepatic echinococcosis | Idiopathic pulmonary fibrosis | Lymphangioleiomyomatosis | Amyotrophic lateral sclerosis | Spinal muscular atrophy | Fabry disease | Pompe disease | Duchenne muscular dystrophy | Behçet disease | Alport syndrome | IgA nephropathy | Gaucher disease | Niemann–Pick disease type C | Osteogenesis imperfecta | Primary biliary cholangitis | Primary sclerosing cholangitis | Congenital diaphragmatic hernia | Hirschsprung disease | Inherited epidermolysis bullosa | Hereditary angioedema | Familial adenomatous polyposis | Leber hereditary optic neuropathy | Majeed syndrome | NGLY1 deficiency | ISG15 deficiency |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PubMed papers, world | 3,268 | 4,349 | 28,695 | 21,069 | 448 | 1,111 | 552 | 5,202 | 1,702 | 4,287 | 1,113 | 9,204 | 1,097 | 1,586 | 1,613 | 1,735 | 2,844 | 431 | 769 | 439 | 1,870 | 1,189 | 2,253 | 1,234 | 687 | 758 | 743 | 804 | 452 | 3,915 | 245 | 6,328 | 560 | 863 | 392 | 2,380 | 1,303 | 360 | 1,731 | 507 | 263 | 772 | 1,006 | 983 | 1,109 | 751 | 786 | 568 | 664 | 315 | 27 | 68 | 18 |
| with a mainland-China author | 2,474 | 2,988 | 15,162 | 10,352 | 165 | 309 | 111 | 2,329 | 564 | 1,169 | 184 | 2,056 | 253 | 507 | 475 | 391 | 309 | 32 | 78 | 76 | 496 | 275 | 520 | 360 | 233 | 223 | 275 | 204 | 167 | 1,028 | 50 | 807 | 63 | 97 | 37 | 241 | 260 | 74 | 767 | 39 | 17 | 109 | 332 | 115 | 60 | 171 | 60 | 36 | 67 | 56 | 5 | 2 | 3 |
| of which in Chinese | 99 | 65 | 397 | 570 | 11 | 8 | 6 | 72 | 41 | 37 | 21 | 380 | 28 | 95 | 76 | 79 | 37 | 5 | 14 | 8 | 11 | 29 | 21 | 4 | 32 | 9 | 11 | 17 | 15 | 39 | 5 | 28 | 8 | 24 | 7 | 28 | 15 | 16 | 31 | 9 | 1 | 10 | 32 | 15 | 0 | 10 | 4 | 4 | 8 | 4 | 2 | 0 | 0 |
| Matched to a named hospital | 92% | 93% | 85% | 91% | 92% | 89% | 97% | 91% | 96% | 75% | 92% | 91% | 92% | 91% | 97% | 87% | 85% | 84% | 92% | 78% | 95% | 95% | 94% | 97% | 88% | 92% | 95% | 96% | 90% | 80% | 92% | 76% | 78% | 90% | 64% | 82% | 95% | 99% | 94% | 76% | 53% | 81% | 93% | 86% | 89% | 90% | 87% | 90% | 85% | 93% | 100% | 33% | 67% |
| No identifiable institution | 2% | 2% | 5% | 4% | 1% | 4% | 2% | 4% | 2% | 7% | 4% | 4% | 2% | 5% | 2% | 6% | 3% | 3% | 3% | 8% | 2% | 1% | 4% | 1% | 6% | 2% | 2% | 0% | 8% | 5% | 0% | 5% | 11% | 6% | 19% | 5% | 2% | 0% | 2% | 5% | 6% | 2% | 4% | 3% | 7% | 4% | 5% | 0% | 4% | 2% | 0% | 0% | 33% |
| Lead authors listing 2+ hospitals | 7% | 6% | 7% | 5% | 3% | 5% | 6% | 5% | 4% | 4% | 4% | 3% | 5% | 4% | 4% | 6% | 5% | – | 3% | 4% | 7% | 3% | 4% | 7% | 6% | 7% | 7% | 3% | 7% | 5% | 4% | 6% | 2% | 1% | 6% | 8% | 5% | 2% | 5% | 4% | – | 4% | 4% | 5% | 7% | 4% | 2% | – | 7% | 11% | – | – | – |
| ClinicalTrials.gov studies, world | 1,138 | 1,039 | 4,062 | 4,383 | 65 | 125 | 67 | 411 | 363 | 648 | 294 | 4,060 | 1,572 | 517 | 125 | 300 | 643 | 42 | 67 | 83 | 190 | 78 | 355 | 67 | 84 | 81 | 19 | 79 | 16 | 584 | 48 | 981 | 297 | 255 | 160 | 488 | 134 | 39 | 242 | 173 | 39 | 83 | 195 | 140 | 88 | 72 | 153 | 168 | 86 | 33 | 0 | 4 | 0 |
| with a site in China | 596 | 567 | 1,465 | 1,462 | 10 | 13 | 6 | 58 | 74 | 42 | 16 | 486 | 253 | 97 | 48 | 47 | 82 | 7 | 6 | 2 | 78 | 43 | 92 | 33 | 16 | 20 | 6 | 25 | 2 | 71 | 2 | 55 | 30 | 14 | 9 | 20 | 17 | 6 | 118 | 12 | 2 | 2 | 50 | 6 | 1 | 12 | 1 | 6 | 3 | 5 | 0 | 0 | 0 |
| Sponsor named only a university | 264 | 143 | 340 | 332 | 2 | 7 | 0 | 5 | 9 | 6 | 3 | 29 | 22 | 7 | 4 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 3 | 5 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 2 | 0 | 0 | 0 | 2 | 1 | 1 | 14 | 1 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| credited to a hospital with one China site | 198 | 104 | 243 | 237 | 1 | 5 | 0 | 2 | 8 | 6 | 2 | 23 | 22 | 6 | 4 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 3 | 2 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 1 | 11 | 1 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| OpenAlex works not in PubMed | 1,094 | 1,173 | 4,675 | 3,257 | – | – | – | – | – | – | – | 1,173 | 217 | 275 | 138 | – | – | – | – | – | 92 | 63 | 187 | 76 | 60 | 47 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Before contacting a hospital
The same for every disease, so it is kept here; each disease page links to it.
How to start
- Talk with the treating doctorWhether a consultation in China would add anything, and whether long-distance travel is advisable, is best discussed first with the doctor who knows the case.
- Prepare medical recordsHospitals usually ask for recent reports, scans and pathology before they reply. They quote costs only after seeing them.
- Ask 2–3 hospitalsWrite to their international offices. Each hospital page has a bilingual enquiry letter you can copy and a Chinese name card to show staff.
Before asking about a trial: questions to check
From the registered criteria
- Is the diagnosis confirmed (pathology or other tests the trial names)?
- Stage or severity, as the trial defines it.
- Earlier treatment: which drugs or procedures, how many lines, and when the last one ended.
- Day-to-day activity level (often scored as ECOG or Karnofsky).
- Recent blood tests: blood counts, liver and kidney function.
- Recent scans, and whether a measurable lesion is required.
- Age range and sex.
- Other conditions the trial excludes, such as hepatitis B or C, HIV, or another cancer.
- Pregnancy, breastfeeding and contraception rules.
To ask the study team
- Does the trial accept participants who are not Chinese citizens or residents?
- In which language are the consent form and questionnaires, and is interpretation provided?
- How many visits, over how long, and how long a stay in China is needed?
- Which costs the trial covers and which are paid separately.
- Whether the visa or permitted stay covers the visit schedule.
- Which records, scans and pathology slides the team needs, and whether they must be translated.
A reading aid only: this site has no form and stores nothing. Meeting the written criteria is not enough; the study team decides after its own screening tests, usually at the hospital.
Common questions
Do hospitals accept international patients?
Each hospital decides after reviewing the medical records. Many large hospitals have an international department.
How are costs set?
Hospitals quote after reviewing records, and prices depend on the treatment. We do not publish estimates.
Can international patients join trials in China?
Each trial sets its own criteria, and many involve regular visits over several months. Eligibility is decided by the trial team; the contact is on each trial's ClinicalTrials.gov page.
Is a visa needed?
Requirements depend on nationality and length of stay; the local Chinese embassy or consulate can confirm them. We do not arrange visas.
Does more research mean better care?
No. It shows which teams work in this area, not the quality of their care or whether they accept a given patient.
Download the data
All tables as of 2026-11-08. They are derived counts; follow the record links for the underlying papers and trials.
- institutions.csvOne row per hospital and disease: shares, counts, ROR and Wikidata IDs, page address.
- systems.csvOne row per university or health system and disease.
- aliases.csvEvery English and Chinese name variant used for each hospital.
- map_data.jsonDisease identifiers, hospital names and research activity counts. See Terms for licences.
- llms.txtPlain-text summary for AI assistants.
Suggest a correction
Tell us when a fact is out of date or wrong: an institution's name, a broken official link, or a paper or trial credited to the wrong place. We check each one against a public source before changing anything.
Please do not send patient stories, reviews, treatment results or any health information. We do not collect it and will delete it.
Page address: What it says now: What it should say: Public source that shows this (link):
Send to: contact@rayknow.com
Independence
We aggregate public sources. Whether a hospital is listed, and in what order, depends only on public records and the written rules on this page.
Updates
One script (run_pipeline.py) downloads, matches and rebuilds every page and stamps the run date. "Official links last checked" is the date a person last opened those links.